Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00094367
Status:
COMPLETED
Last Update Posted:
2010-09-30
First Post:
2004-10-16
Brief Title:
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets ALOHA Study
Sponsor:
Organization:
GlaxoSmithKline